BCL2 and melanoma: Chetoui’s group demonstrated that Mcl-1, an anti-apoptotic protein from the Bcl-2 family that is regulated by extracellular signal-regulated kinases (ERK) signaling pathway, contributes significantly to the drug resistance of melanoma cells [45].